NRX Pharmaceuticals Inc

NASDAQ:NRXP   3:59:30 PM EDT
0.57
-0.03 (-4.83%)
Products

NRX Pharmaceuticals Says FDA Denied Breakthrough Therapy Designation Request For Zyesami (Aviptadil)

Published: 06/11/2022 02:58 GMT
NRX Pharmaceuticals Inc (NRXP) - Nrx Pharmaceuticals Provides Update on Breakthrough Therapy Designation (btd) Request for Zyesami® (aviptadil).
Nrx Pharmaceuticals- U.S. Food and Drug Administration (fda) Denied the Breakthrough Therapy Designation (btd) Request for Zyesami® (aviptadil).